Cooperative lesions may favor the aggressive phenotype of a leukemia, such as exemplified by the synergistic effect between loss of IKZF1 and the BCR-ABL1 fusion gene in leukemogenesis30, and the antagonizing effect of IKZF1 deletions in the response to imatinib31. The gene discussed is ABL1; the disease is leukemia.